Home >
News >
#ESHMDS2022 ON-DEMAND PROGRAMME STILL AVAILABLE!
#ESHMDS2022 ON-DEMAND PROGRAMME STILL AVAILABLE!
April 19, 2022
8th Translational Research Conference
MYELODYSPLASTIC SYNDROMES
April 7-10, 2022
#ESHMDS2022
FREE REGISTRATION
DO NOT MISS THIS OPPORTUNITY!
Relive or discover all the discussions and talks of the
ESH 8th Translational Research Conference:
MYELODYSPLASTIC SYNDROMES!
Pierre Fenaux, Uwe Platzbecker & Mikkael Sekeres
are surrounded by a faculty of global experts to share
their knowledge on Myelodysplastic Syndromes.
The E-Conference platform will remain open until May 10th, 2022.
Thank you to the faculty
TIMING OF THE SCIENTIFIC PROGRAMME:
To make sure that everyone has access to the full scientific programme
at a convenient hour, registration will allow participants to join
the PROGRAMME ON-DEMAND UNTIL MAY 10, 2022
To read the scientific programme, click here!
For more information, click here!
The "Programme on-demand" is available until May 10, 2022.
It initially includes the pre-recorded components of the scientific programme.
It will be progressively enriched by the meeting’s live, interactive components which will be recorded real time during the meeting.
E-POSTERS
March 1 - April 13, 2022
The Poster Hall will also remain open until May 10, 2022.
The Mentored Poster Walk will be recorded real time.
It will thereafter become available within the Programme on-demand.
VIRTUAL EXHIBITION
March 29 - May 10, 2022
We invite you to visit the Exhibition area as of March 29, 2022.
Our corporate partners will be pleased to welcome and chat with you.
SATELLITE SYMPOSIA LIVE AND ON-DEMAND:
Symposia organized independently by our corporate partners, in conjunction with
the ESH 8th Translational Research E-Conference on Myelodysplatics Syndromes,
will also be available Live and On-Demand, as described above.
With the support of*:
Diamond E-Conference Partner
******
Emerald E-Conference Partner
******
Ruby E-Conference Partners
******
*ESH conference programs are developed in strict scientific independence
with no input from corporate sponsors.
